Business · 1 sources covering this

NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.
A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/9f2dd8c59c5baaa62e29f8b4a2d4ca34b427d83f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have."></iframe>

NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

How 1 sources are covering this

NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

More from Business

Russia could attack a NATO country within months, Danish intelligence warns

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

U.S. Treasury yields tick higher as global bond rout slows

Iran offers to reopen Strait of Hormuz within 7 days and restart nuclear talks

Reader

Trust & legal

Across the network